Drug Discovery in Cancer Epigenetics

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Science & Nature, Science, Biological Sciences, Genetics
Cover of the book Drug Discovery in Cancer Epigenetics by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128024928
Publisher: Elsevier Science Publication: November 19, 2015
Imprint: Academic Press Language: English
Author:
ISBN: 9780128024928
Publisher: Elsevier Science
Publication: November 19, 2015
Imprint: Academic Press
Language: English

Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

  • Highlights the potential of epigenetic alterations in cancer for drug development
  • Covers the tools and methods for epigenetic drug discovery, preclinical and clinical testing, and clinical implications of epigenetic therapy
  • Provides important information regarding putative epigenetic targets, epigenetic technologies, networks and consortia for epigenetic drug discovery and routes for translation
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

More books from Elsevier Science

Cover of the book A Historical Perspective on Evidence-Based Immunology by
Cover of the book Experiencing Change in German Controlling by
Cover of the book Self-diffusion and Impurity Diffusion in Pure Metals by
Cover of the book Nuclear Fuel Cycle Science and Engineering by
Cover of the book Advances in Quantum Chemistry by
Cover of the book Rock Fracture and Blasting by
Cover of the book Astronomical Optics by
Cover of the book Division of Labor in Cells by
Cover of the book Advances in Atomic, Molecular, and Optical Physics by
Cover of the book Construction Hazardous Materials Compliance Guide by
Cover of the book Wireless Reconnaissance in Penetration Testing by
Cover of the book Information Hiding in Speech Signals for Secure Communication by
Cover of the book Multidimensional Systems Signal Processing Algorithms and Application Techniques by
Cover of the book Success in Innovation by
Cover of the book Food Safety and Quality Systems in Developing Countries by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy